Desq Long
Sign in

Company

AIM ImmunoTech Inc.

AIM · CIK 0000946644

SEC FORM 4
$4,992.00

AIM ImmunoTech Inc. (AIM)

Purchase of 24,000 shares at $0.208 per share.

Reporting Person Equels Thomas K · Officer Title CEO & President · Transaction Code P

Traded Sep 17, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001493152-26-043246 · filed 2026-09-18 · View filing →

SEC FORM 4
$2,310.00

AIM ImmunoTech Inc. (AIM)

Purchase of 11,000 shares at $0.210 per share.

Reporting Person Equels Thomas K · Officer Title CEO & President · Transaction Code P

Traded Sep 16, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001493152-26-043073 · filed 2026-09-17 · View filing →

SEC FORM 4
$4,862.00

AIM ImmunoTech Inc. (AIM)

Purchase of 22,000 shares at $0.221 per share.

Reporting Person Equels Thomas K · Officer Title CEO & President · Transaction Code P

Traded Sep 15, 2026 · Disclosed Sep 16, 2026

Source: SEC Form 4 · 0001493152-26-042848 · filed 2026-09-16 · View filing →

SEC FORM 4
$1,292.10

AIM ImmunoTech Inc. (AIM)

Purchase of 5,900 shares at $0.219 per share.

Reporting Person Equels Thomas K · Officer Title CEO & President · Transaction Code P

Traded Sep 14, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001493152-26-042754 · filed 2026-09-15 · View filing →